Tremor Monitoring Device

October 30, 2017 updated by: Ilana Schlesinger, Rambam Health Care Campus
Patients with tremor may have varying degrees of tremor at different times. The amplitude and frequency of tremor may change. The investigators observational study is intended to document this tremor.

Study Overview

Status

Completed

Study Type

Observational

Enrollment (Actual)

18

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Sampling Method

Probability Sample

Study Population

Patients with tremor due to Parkinson's disease or Essential tremor will be included

Description

Inclusion Criteria:

  • Patients with tremor due to Parkinson's disease or Essential tremor

Exclusion Criteria:

  • Severe dementia

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Patients with Parkinson's Disease
Patients with tremor due to Parkinson Disease
Patients with Essential tremor
Patients with tremor due to Essential tremor

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Maximum linear acceleration of the forearm.
Time Frame: Linear acceleration of the forearm will be measured for 15-60 minutes.
We will measure linear acceleration of the forearm in meter per second squared.
Linear acceleration of the forearm will be measured for 15-60 minutes.

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Maximum angular velocity of the forearm.
Time Frame: Maximum angular velocity of the forearm will be measured for 15-60 minutes.
We will measure angular velocityof the forearm in degrees per second.
Maximum angular velocity of the forearm will be measured for 15-60 minutes.

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Ilana Schlesinger, M.D., Rambam Health Care Campus

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

September 1, 2015

Primary Completion (Actual)

October 30, 2017

Study Completion (Actual)

October 30, 2017

Study Registration Dates

First Submitted

August 10, 2015

First Submitted That Met QC Criteria

August 12, 2015

First Posted (Estimate)

August 14, 2015

Study Record Updates

Last Update Posted (Actual)

October 31, 2017

Last Update Submitted That Met QC Criteria

October 30, 2017

Last Verified

October 1, 2017

More Information

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Parkinson's Disease

3
Subscribe